Joseph Siletto, is a Managing Director of Vivo Capital. Mr. Siletto invests in growth equity and private equity and actively involved with the investments in Surgical Specialties Corporation and Preventice Solutions.
Mr. Siletto has over 20 years of experience in life sciences transactions and investments as a CEO to a private company, Investment Banker and Investor. Prior to joining Vivo, he co-founded Scion Medical, a commercial-stage, China-US cross border medical device roll-up in the interventional oncology segment which Varian Medical (NYSE: VAR) acquired in 2019. Earlier in his career, Mr. Siletto was an Investment Banker for Banc of America Securities and Cowen Inc..
He received his B.A. from Duke University and an M.B.A. from the University at California at Berkeley. Mr Siletto, studied at Beijing Language Institute.